BlackRock’s iHuman IH Stock Holding History

BlackRock’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-320	Closed	-$546	–	5799
2026 Q1	$546	Sell	320 -17	-5%	-$32	﹤0.01%	5571
2025 Q4	$708	Sell	337 -79	-19%	-$209	﹤0.01%	5433
2025 Q3	$1.2K	Buy	416 +96	+30%	+$266	﹤0.01%	5345
2025 Q2	$800	Buy	+320	New	+$713	﹤0.01%	5363
2022 Q3	–	Sell	-175	Closed	–	–	5859
2022 Q2	$0	Buy	+175	New	+$461	﹤0.01%	5907
2021 Q4	–	Sell	-2,482	Closed	-$12K	–	5816
2021 Q3	$12K	Sell	2,482 -46,690	-95%	-$348K	﹤0.01%	5441
2021 Q2	$508K	Sell	49,172 -26,081	-35%	-$287K	﹤0.01%	4690
2021 Q1	$941K	Buy	+75,253	New	+$1.33M	﹤0.01%	4511

Other funds holding IH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock's IH Position: Q2 2026 in Review

BlackRock sold out of iHuman (IH) in Q2 2026, closing a stake of 320 shares — an estimated $546 sold.

BlackRock first reported a position in IH in Q1 2021 and held it in 8 quarters. The position peaked at $941K in Q1 2021. 4 funds tracked by Wall St. Rank hold IH as of Q2 2026.

BlackRock reported no remaining iHuman position as of Q2 2026 after selling out during the quarter.
BlackRock sold 320 iHuman shares in Q2 2026, an estimated $546.
BlackRock first reported a position in iHuman in Q1 2021 and held it in 8 quarters.
BlackRock's iHuman position peaked at $941K in Q1 2021.
4 funds tracked by Wall St. Rank held iHuman as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.